Cecilia Furlong
Stock Analyst at Morgan Stanley
(2.11)
# 1,277
Out of 4,641 analysts
189
Total ratings
38.27%
Success rate
-4.37%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Equal-Weight | $460 → $475 | $517.50 | -8.21% | 12 | Jul 19, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $14.17 | -15.31% | 12 | Jul 15, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $5.4 → $6.5 | $5.65 | +15.04% | 14 | Jul 15, 2024 | |
| NVRO Nevro | Maintains: Equal-Weight | $14 → $9 | $5.15 | +74.76% | 8 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $75.59 | +71.98% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $104.26 | +15.10% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $122.94 | -22.73% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $91.12 | +7.55% | 9 | Nov 22, 2023 | |
| AXNX Axonics | Maintains: Overweight | $76 → $69 | $70.29 | -1.84% | 5 | Oct 31, 2023 | |
| NARI Inari Medical | Reiterates: Overweight | $83 | $44.44 | +86.77% | 10 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $85 | $94.64 | -10.19% | 9 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $15 | $26.53 | -43.46% | 4 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $325 → $343 | $236.60 | +44.97% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $6.13 | +128.38% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $36.59 | +31.18% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $69.24 | +47.31% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $88.01 | -34.10% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $20.35 | -1.72% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $73.08 | +79.26% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $116.12 | +14.54% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $366.02 | -39.89% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $236.71 | +59.69% | 2 | Feb 25, 2022 |
Intuitive Surgical
Jul 19, 2024
Maintains: Equal-Weight
Price Target: $460 → $475
Current: $517.50
Upside: -8.21%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $14.17
Upside: -15.31%
Sight Sciences
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.4 → $6.5
Current: $5.65
Upside: +15.04%
Nevro
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $14 → $9
Current: $5.15
Upside: +74.76%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $75.59
Upside: +71.98%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $104.26
Upside: +15.10%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $122.94
Upside: -22.73%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $91.12
Upside: +7.55%
Axonics
Oct 31, 2023
Maintains: Overweight
Price Target: $76 → $69
Current: $70.29
Upside: -1.84%
Inari Medical
Aug 3, 2023
Reiterates: Overweight
Price Target: $83
Current: $44.44
Upside: +86.77%
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $94.64
Upside: -10.19%
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $26.53
Upside: -43.46%
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $236.60
Upside: +44.97%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $6.13
Upside: +128.38%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $36.59
Upside: +31.18%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $69.24
Upside: +47.31%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $88.01
Upside: -34.10%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $20.35
Upside: -1.72%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $73.08
Upside: +79.26%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $116.12
Upside: +14.54%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $366.02
Upside: -39.89%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $236.71
Upside: +59.69%